ES2160125T3 - Proceso para la sintesis de azetidinonas. - Google Patents

Proceso para la sintesis de azetidinonas.

Info

Publication number
ES2160125T3
ES2160125T3 ES94921407T ES94921407T ES2160125T3 ES 2160125 T3 ES2160125 T3 ES 2160125T3 ES 94921407 T ES94921407 T ES 94921407T ES 94921407 T ES94921407 T ES 94921407T ES 2160125 T3 ES2160125 T3 ES 2160125T3
Authority
ES
Spain
Prior art keywords
substituted
pct
beta
amino
azetidinones
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94921407T
Other languages
English (en)
Inventor
Tiruvettipuram K Thiruvengadam
Timothy Mcallister
Chou-Hong Tann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22217215&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2160125(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ES2160125T3 publication Critical patent/ES2160125T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams

Abstract

ESTA INVENCION PROPORCIONA UN PROCESO PARA PREPARAR ACETIDINONAS UTILES COMO INTERMEDIO EN LA SINTESIS DE PENEMOS Y COMO AGENTES HIPOCOLESTEROLEMICOS, PARTICULARMENTE PARA ACETIDINONAS SUSTITUIDAS EN LAS POSICIONES C-3 Y C-4 Y OPCIONALMENTE SUSTITUIDAS EN EL NITROGENO EN ANILLO, QUE CONSISTE EN REACCIONAR UN BETA-(AMINOSUSTITUIDO) AMIDA, UN ESTER DE BETA(AMINOSUSTITUIDO) ACIDO O UN ESTER DE BETA-(AMINOSUSTITUIDO) ACIDO TIOLCARBONICO CON UN AGENTE DE SILILACION Y UN AGENTE DE CICLIZACION.
ES94921407T 1993-07-09 1994-07-01 Proceso para la sintesis de azetidinonas. Expired - Lifetime ES2160125T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8935793A 1993-07-09 1993-07-09

Publications (1)

Publication Number Publication Date
ES2160125T3 true ES2160125T3 (es) 2001-11-01

Family

ID=22217215

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94921407T Expired - Lifetime ES2160125T3 (es) 1993-07-09 1994-07-01 Proceso para la sintesis de azetidinonas.

Country Status (21)

Country Link
US (1) US5728827A (es)
EP (1) EP0707567B1 (es)
JP (1) JP2840452B2 (es)
KR (1) KR0176001B1 (es)
CN (1) CN1071745C (es)
AT (1) ATE205475T1 (es)
AU (1) AU681419B2 (es)
CA (1) CA2166784C (es)
CZ (1) CZ7696A3 (es)
DE (1) DE69428280T2 (es)
DK (1) DK0707567T3 (es)
ES (1) ES2160125T3 (es)
FI (1) FI960095A0 (es)
HU (1) HUT73237A (es)
MX (1) MX9405152A (es)
NO (1) NO306294B1 (es)
NZ (1) NZ268798A (es)
PL (1) PL312502A1 (es)
PT (1) PT707567E (es)
SK (1) SK3796A3 (es)
WO (1) WO1995001961A1 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5631365A (en) 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
US6207822B1 (en) 1998-12-07 2001-03-27 Schering Corporation Process for the synthesis of azetidinones
EP1137634B1 (en) * 1998-12-07 2005-06-15 Schering Corporation Process for the synthesis of azetidinones
AU4343500A (en) 1999-04-16 2000-11-02 Schering Corporation Use of azetidinone compounds
US20060287254A1 (en) * 2001-01-26 2006-12-21 Schering Corporation Use of substituted azetidinone compounds for the treatment of sitosterolemia
ATE374641T1 (de) * 2001-01-26 2007-10-15 Schering Corp Kombinationen vom ppar-aktivator fenofibrat mit dem hemmer der sterol-absorption ezetimibe zur behandlung von kardiovaskulären indikationen
IL157552A0 (en) * 2001-03-28 2004-03-28 Schering Corp Enantioselective synthesis of azetidinone intermediate compounds
US7053080B2 (en) * 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
ATE345793T1 (de) * 2001-09-21 2006-12-15 Schering Corp Behandlung von xanthom mittels azetidinon- derivate als hemmer der sterol absorption
US20030204096A1 (en) * 2002-03-25 2003-10-30 Schering Corporation Enantioselective synthesis of azetidinone intermediate compounds
GB0215579D0 (en) 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds
US7135556B2 (en) * 2002-07-19 2006-11-14 Schering Corporation NPC1L1 (NPC3) and methods of use thereof
ES2311806T3 (es) * 2003-03-07 2009-02-16 Schering Corporation Compuesto de azetidinona sustituidos, fornulaciones y usos de los mismos para el tratamiento de hipercolesterolemia.
US7459442B2 (en) * 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
EP1601669B1 (en) * 2003-03-07 2008-12-24 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
AU2004308332B2 (en) * 2003-12-23 2008-04-10 Merck Sharp & Dohme Corp. Anti-hypercholesterolemic compounds
US7871998B2 (en) 2003-12-23 2011-01-18 Astrazeneca Ab Diphenylazetidinone derivatives possessing cholesterol absorption inhibitory activity
MXPA06008124A (es) * 2004-01-16 2007-01-26 Merck & Co Inc Npc1l1 (npc3) y metodos para identificar ligandos del mismo.
DE102004025071B4 (de) * 2004-05-21 2006-12-21 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung von Diphenylazetidinon-Derivaten
ES2294712T3 (es) 2004-05-21 2008-04-01 Sanofi-Aventis Deutschland Gmbh Procedimiento para la preparacion de derivados de 1,4-difenilazetidinona.
JP4890466B2 (ja) 2004-12-20 2012-03-07 シェーリング コーポレイション アゼチジノンの合成のためのプロセス
US7635705B2 (en) * 2005-06-20 2009-12-22 Schering Corporation Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists
SA06270191B1 (ar) 2005-06-22 2010-03-29 استرازينيكا ايه بي مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
US7910698B2 (en) 2006-02-24 2011-03-22 Schering Corporation NPC1L1 orthologues
AR060623A1 (es) 2006-04-27 2008-07-02 Astrazeneca Ab Compuestos derivados de 2-azetidinona y un metodo de preparacion
WO2008030382A1 (en) * 2006-09-05 2008-03-13 Schering Corporation Pharmaceutical combinations for lipid management and in the treatment of atherosclerosis and hepatic steatosis
WO2008032338A2 (en) * 2006-09-11 2008-03-20 Manne Satyanarayana Reddy Improved process for the preparation of ezetimibe and its intermediates
CN101679236B (zh) 2007-01-24 2013-03-06 克尔克公司 依泽替米贝的制备方法和其的衍生物
CA2757722C (en) 2009-04-01 2018-05-22 Matrix Laboratories Ltd. Enzymatic process for the preparation of (s)-5-(4-fluoro-phenyl)-5-hydroxy- 1morpholin-4-yl-pentan-1-one, an intermediate of ezetimibe and further conversion to ezetimibe
CN104803858B (zh) * 2014-01-23 2019-03-01 东莞东阳光科研发有限公司 一种制备四丁基氟化铵三水合物的方法
EP4097099A4 (en) 2020-02-07 2023-09-27 Gasherbrum Bio, Inc. HETEROCYCLIC GLP-1 AGONISTS

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0333268A1 (en) * 1988-03-18 1989-09-20 Merck & Co. Inc. Process for synthesis of a chiral 3-beta hydrogen (3R) 4-aroyloxy azetidinone
US4876365A (en) * 1988-12-05 1989-10-24 Schering Corporation Intermediate compounds for preparing penems and carbapenems
US4983597A (en) * 1989-08-31 1991-01-08 Merck & Co., Inc. Beta-lactams as anticholesterolemic agents
US5085473A (en) * 1990-10-09 1992-02-04 Yuhe Yang Air actuated car curtain device
EP0524595A1 (en) * 1991-07-23 1993-01-27 Schering Corporation Substituted beta-lactam compounds useful as hypocholesterolemic agents and processes for the preparation thereof

Also Published As

Publication number Publication date
KR0176001B1 (ko) 1999-03-20
ATE205475T1 (de) 2001-09-15
CN1071745C (zh) 2001-09-26
AU7214694A (en) 1995-02-06
MX9405152A (es) 1995-01-31
EP0707567B1 (en) 2001-09-12
PL312502A1 (en) 1996-04-29
JP2840452B2 (ja) 1998-12-24
NZ268798A (en) 1997-01-29
HUT73237A (en) 1996-07-29
EP0707567A1 (en) 1996-04-24
HU9503748D0 (en) 1996-02-28
NO306294B1 (no) 1999-10-18
CZ7696A3 (en) 1996-04-17
NO960083D0 (no) 1996-01-08
SK3796A3 (en) 1997-02-05
CA2166784A1 (en) 1995-01-19
WO1995001961A1 (en) 1995-01-19
DE69428280D1 (de) 2001-10-18
KR960703853A (ko) 1996-08-31
FI960095A (fi) 1996-01-09
DE69428280T2 (de) 2002-06-13
AU681419B2 (en) 1997-08-28
CN1126989A (zh) 1996-07-17
FI960095A0 (fi) 1996-01-09
JPH08507085A (ja) 1996-07-30
DK0707567T3 (da) 2001-11-26
US5728827A (en) 1998-03-17
NO960083L (no) 1996-03-04
CA2166784C (en) 2001-12-11
PT707567E (pt) 2002-01-30

Similar Documents

Publication Publication Date Title
ES2160125T3 (es) Proceso para la sintesis de azetidinonas.
PL318100A1 (en) 2-[(dihydro) pyrazolyl-3'-oxymethylene]anilides, method of obtaining them and their application
IL113141A0 (en) Intermediates for hypoglycemic hydroxyurea detivatives
DE59914996D1 (en) Heterocyclisch substituierte amide als calpainhemmer
AP9701018A0 (en) Squalene synthetase inhibitor compounds.
ES2194960T3 (es) N-(2-sustituido-3-(2-aminoetil)-1h-indol-5-il)-amidas como nuevos agonistas de 5-ht1f.
TR200001012T2 (tr) Yeni ariloksi-alkil-dialkilaminler.
DK75593D0 (es)
IL172973A (en) Process for the preparation of (4s, 5r) - n - boc - 2 - (2' 4 - dimethoxyphenyl) - 4 - isobutyl - 1 - oxazolidine - 5 - carboxylic acid
PT687260E (pt) Processo para a preparacao de 9-desoxotaxanos
ID23053A (id) Karboksamida yang digunakan sebagai agonis 5-ht <if>
ZA961364B (en) 1-Aryl-2-acylamino-ethane compounds
NZ331875A (en) Asymmetric synthesis of R-alpha-propyl-piperonyl amine and its analogs
HK1088325A1 (en) Process for the preparation of baccatin III derivatives
BG104243A (en) Method for the synthesis of quinoline derivatives
YU12000A (sh) Supstituisani 1,2,3,4,5,6-heksahidro-2,6-metano-3-benzazocin -10-oli, postupak za njihovo pripremanje i njihova primena kao lekova
PL350568A1 (en) N-(2-phenyl-4-aminobutyl)-1-naphtamides as antagonists of neurokinin 1 receptors
MY133666A (en) Enzymatic process for stereoselective preparation of therapeutic amides
MX9701569A (es) Pirimidin(tio)onas substituidas.
IN190402B (es)
MX9701525A (es) Cristales de glicosidos de espiroestanilo.
UA74426C2 (uk) Фенілпіперазини
PT1019347E (pt) Metodo para a sintese de taxanos
EP0734255A4 (en) NEW POTASSIUM CHANNEL AGONIST RECEIVED BY TRICHODERMA VIRENS
IL133410A0 (en) Novel pentaerythrite derivatives, the production and use thereof and intermediate products for the synthesis of the same

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 707567

Country of ref document: ES